Feed CHJTF
CH

CSPC Pharmaceutical Group Limited CHJTF · OTC

$1.26 +13.51% (+$0.15)

Summary

71 / 100 · Bulios Score

What speaks for it

  • Out of every 100 CNY of revenue, 24 CNY is left as net profit.
  • It holds more cash than debt: ¥10.0B against ¥652.5M.
  • It earns 17 CNY a year on every 100 CNY of invested capital.
  • Analysts expect revenue to grow by 53% this fiscal year.

What to watch

  • Revenue fell by 6.5% a year over the last 3 years.
  • It cut its dividend by 20% last year.
  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $1.26
P/E today 13.1
Drug Manufacturers - General industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 13.1 CNY for 1 CNY of yearly profit.

Valuation in detail

Is it growing?

It is shrinking

Revenue (CNY)

Diluted EPS (CNY)

  • Analyst estimate

Revenue grew by 0.3% a year over 5 years. Over the last 3 years it fell by 6.5% a year. For the next fiscal year analysts expect revenue to grow by 53%. Earnings per share fell by 14% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 CNY of revenue goes

Net profit, industry median (Drug Manufacturers - General) 14 CNY

Out of every 100 CNY of revenue, 24 CNY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Moderate, at risk
Yield
3.65%
Paid out of profit
48%

You receive $0.05 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy